Journées québécoises de valorisation des données – Nadine Beauger invited Speaker

Nadine Beauger, Chief Executive Officer of IRICoR, participates to the first edition of the “Journées québécoises de valorisation des données” organized by the Institute for Data Valorisation (IVADO) and the Big Data Research Centre (BDRC) of Université Laval to present the innovative business model of IRICoR.
As Université de Montréal’s drug discovery and […]

IRICoR is pleased to share news from our partner, Domain Therapeutics.

Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor bioSens-All™ technology
Technology provides access to new generation of sensitive biosensors to enhance drug discovery
Strasbourg, France, February 27, 2018 – Domain Therapeutics, a France- and Quebec-based biopharmaceutical company that specializes in the research and development of new drug candidates that target transmembrane receptors, today announces the signing of a licensing […]

In vivo science and artificial intelligence join forces to advance tools in cancer treatment and management

Montreal, February 8, 2018 — It will become easier to discover imaging biomarkers and identify digital surrogates for modern end-points in personalized therapies, thanks to a partnership between Sylvain Meloche – Principal Investigator within the signaling and cell growth research unit at the Institute for Research in Immunology and Cancer (IRIC) along with his team, and Imagia, an […]

MEDTEQ’s 6th Annual Forum – Nadine Beauger Speaker

Nadine Beauger, Chief Executive Officer of IRICoR, participates in the MEDTEQ’s 6th Annual Forum to present the innovative business model of IRICoR.
As Université de Montréal’s drug discovery and project maturation cluster, IRICoR brings together a team of expert working to accelerate the discovery of drugs. In recent years, new alliances between academia and the pharmaceutical industry have emerged […]

IRICoR will attend the 10th Biotech Showcase Conference in San Francisco

IRICoR will attend the 10th Biotech Showcase Conference in San Francisco, January 8-10, 2018.
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor […]

Launch of the Life Sciences Entrepreneurship Development Executive Program

IRICoR is proud to join the efforts of Montreal InVivo, Concordia University’s John Molson Executive Centre, and the Faculty of Pharmacy at Université de Montréal to provide advanced management training to students and professionals in the field of life sciences.
Its team not only encourages the initiative, but is proud to be part of this dynamic new program via its contribution […]

IRICoR to attend BIO-Europe 2017

The Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) of Université de Montréal will attend the 23rd  Annual International Partnering Conference BIO-Europe. This conference is being held from November 6 to November 8, 2017 at the CityCube in Berlin, Germany.
IRICoR will be participating for the seventh consecutive year in this industry event that aims to create business opportunities between life […]

IRICoR congratulates M. Michel Bouvier for being awarded the prestigious prix Wilder-Penfield

On November 1st, Michel Bouvier will receive the prix Wilder-Penfield for his scientific contribution to the advancement of the biomedical field.

Professor Michel Bouvier, Chief Executive Officer of the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal (UdeM) and professor in the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine, was named recipient of […]

IRICoR to present at next LES workshop – Montreal, Quebec

IRICoR is proud to announce the Dr. Steven Klein, Vice-President Business Development at IRICoR is invited as a speaker at the next Licensing Executives Society workshop to be held September 26, 2017 in Montreal.
The conference will be entitled “Do’s and don’ts in deal negotiation between private industry and universities”. Discussions will focus on the impact a case study: Domain Therapeutics […]

SpecificiT Pharma Raises Seed Financing

Company is advancing a clinical-stage novel immunotherapy based on technology developed with the support of IRICoR
MONTREAL, QC, September 11, 2017 – SpecificiT Pharma Inc., a privately held Montreal-based biopharmaceutical company focused on developing innovative personalized hematological cancer immunotherapies, is pleased to announce the completion of a seed financing by existing shareholder AmorChem, along with new partners, Sanderling Ventures and Accel-Rx […]

Next Page »